Jumalon, Virginia V.
HRN: 26-20-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2024
CEFUROXIME 750MG (VIAL)
11/14/2024
11/21/2024
IV
750
Q8
Uti, Mandibular Mass With Abscess
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes